CEND-1 Offers Hope in Advanced Pancreatic Cancer
(MedPage Today) -- Chemotherapy combined with the CEND-1 cyclic peptide showed promising efficacy, and was well tolerated as a first-line treatment, for patients with metastatic pancreatic cancer, researchers reported.
In a phase I study of 29...
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news
More News: Cancer | Cancer & Oncology | Chemotherapy | Gastroenterology | Pancreas | Pancreatic Cancer | Study